Antigen-Fc fusion therapy reduces severity of a model of pemphigus vulgaris without systemic immunosuppression | Science Translational Medicine
An engineered Dsg3-Fc fusion protein delays disease onset and reduces severity in pemphigus vulgaris without inducing global immunosuppression.
